Advertisement

Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px
Document › Details

Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert.

Organisations Organisation Celyad S.A. (Euronext Brussels + Paris: CYAD, Nasdaq: CYAD)
  Group Celyad (Group)
  Organisation 2 Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO)
Products Product shRNA technology
  Product 2 CYAD-01 (CAR-T NKG2D) CAR T-cell therapy
Persons Person Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)
  Person 2 Zelkovic, Sara (Astellas 202412 RnD Communciations formerly LifeSci Public Relations)
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Celyad (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x300px




» top